Bilaketaren emaitzak - Ozge Tatli

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy nork Ozge Tatli, Gizem Dinler Doganay

Testu osoa

Understanding the characteristic behaviour of the wild-type and mutant structure of FLT3 protein by computational methods nork Saleena Younus, Özge Tatli, Ahmad Nasimian, Julhash U. Kazi, Lars Rönnstrand

Testu osoa

Co-Chaperone Bag-1 Plays a Role in the Autophagy-Dependent Cell Survival through Beclin 1 Interaction nork Miray Turk, Ozge Tatli, Hamza Furkan Alkan, Pelin Ozfiliz Kilbas, Gizem Alkurt, Gizem Dinler Doganay

Testu osoa

X-ray crystallographic and hydrogen deuterium exchange studies confirm alternate kinetic models for homolog insulin monomers. nork Esra Ayan, Miray Türk, Özge Tatlı, Sevginur Bostan, Elek Telek, Baran Dingiloğlu, B Züleyha Doğan, Muhammed Ikbal Alp, Ahmet Katı, Gizem Dinler-Doğanay, Hasan Demirci

Testu osoa

A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer nork Ozge Tatli, Ecenur Cebi, Miray Turk, Baran Dingiloglu, Aycan Sezan, Ezgi Basturk, Betul Zehra Temur, Alp Ertunga Eyupoglu, Berna Bicak, Esra Erdal, Batu Erman, Özge Can, Gizem Dinler Doganay

Testu osoa

A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab nork Ozge Tatli, Yagmur Oz, Baran Dingiloglu, Duygu Yalcinkaya, Ezgi Basturk, Melis Korkmaz, Latif Akbulut, Derya Hatipoglu, Cansin Kirmacoglu, Buse Akgun, Kubra Turk, Orkun Pinar, Berna Sariyar Akbulut, Zeynep Atabay, Eda Tahir Turanli, Dilek Kazan, Gizem Dinler Doganay

Testu osoa